☰

cached image

Gianpiero Di Leva - Publications

Affiliations: 
University of Salford, UK 
Area:
microRNA
Website:
https://www.salford.ac.uk/environment-life-sciences/our-staff/els-academics/gianpiero-di-leva
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, et al. Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell. PMID 36306794 DOI: 10.1016/j.ccell.2022.10.005  0.655
2022 Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306793 DOI: 10.1016/j.ccell.2022.10.006  0.608
2022 Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306791 DOI: 10.1016/j.ccell.2022.10.007  0.608
2022 Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, et al. Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine. PMID 36195688 DOI: 10.1038/s41591-022-02044-2  0.383
2022 Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 17: e0267628. PMID 35443005 DOI: 10.1371/journal.pone.0267628  0.479
2021 Corrà F, Crudele F, Baldassari F, Bianchi N, Galasso M, Minotti L, Agnoletto C, Di Leva G, Brugnoli F, Reali E, Bertagnolo V, Vecchione A, Volinia S. UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines. Genes. 12. PMID 34946928 DOI: 10.3390/genes12121978  0.482
2021 Shi L, Magee P, Fassan M, Sahoo S, Leong HS, Lee D, Sellers R, Brullé-Soumaré L, Cairo S, Monteverde T, Volinia S, Smith DD, Di Leva G, Galuppini F, Paliouras AR, et al. A KRAS-responsive long non-coding RNA controls microRNA processing. Nature Communications. 12: 2038. PMID 33795683 DOI: 10.1038/s41467-021-22337-3  0.366
2018 Galasso M, Morrison C, Minotti L, Corrà F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D'Atri S, Alvino E, Previati M, et al. Loss of miR-204 expression is a key event in melanoma. Molecular Cancer. 17: 71. PMID 29523154 DOI: 10.1186/S12943-018-0819-8  0.57
2017 De Santi C, Melaiu O, Bonotti A, Cascione L, Di Leva G, Foddis R, Cristaudo A, Lucchi M, Mora M, Truini A, Tironi A, Murer B, Boldorini R, Cipollini M, Gemignani F, et al. Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism. Scientific Reports. 7: 3140. PMID 28600498 DOI: 10.1038/s41598-017-02694-0  0.526
2016 Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. 30: 349-351. PMID 27505674 DOI: 10.1016/J.Ccell.2016.07.007  0.608
2016 D'Ippolito E, Plantamura I, Bongiovanni L, Casalini P, Baroni S, Piovan C, Orlandi R, Gualeni AV, Gloghini A, Rossini A, Cresta S, Tessari A, de Braud F, Di Leva G, Tripodo C, et al. MiR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of tumor cells in triple negative breast cancer. Cancer Research. PMID 27402080 DOI: 10.1158/0008-5472.CAN-16-0140  0.485
2015 Di Leva G, Cheung DG, Croce CM. miRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Review of Endocrinology & Metabolism. 10: 607-617. PMID 27721895 DOI: 10.1586/17446651.2015.1099430  0.615
2015 Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley KJ, Selmi T, Naidu S, Farber JL, Croce CM, Fong LY. Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. Journal of the National Cancer Institute. 107. PMID 26286729 DOI: 10.1093/Jnci/Djv220  0.541
2015 Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 10: e0131729. PMID 26110899 DOI: 10.1371/journal.pone.0131729  0.492
2015 Jeon YJ, Middleton J, Kim T, Laganà A, Piovan C, Secchiero P, Nuovo GJ, Cui R, Joshi P, Romano G, Di Leva G, Lee BK, Sun HL, Kim Y, Fadda P, et al. A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: E3355-64. PMID 26080425 DOI: 10.1073/Pnas.1504630112  0.651
2014 Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Garzon ME, Di Leva G, Gasparini P, Dama P, et al. Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. Journal of the National Cancer Institute. 106. PMID 25306216 DOI: 10.1093/Jnci/Dju324  0.427
2014 Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S, Bottoni A, Rosito IA, Liu CG, Burch A, Acunzo M, Pekarsky Y, et al. MicroRNA profiles discriminate among colon cancer metastasis. Plos One. 9: e96670. PMID 24921248 DOI: 10.1371/Journal.Pone.0096670  0.465
2014 Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annual Review of Pathology. 9: 287-314. PMID 24079833 DOI: 10.1146/Annurev.Med.59.053006.104707  0.51
2013 Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 8: e67581. PMID 23805317 DOI: 10.1371/Journal.Pone.0067581  0.58
2013 Di Leva G, Croce CM. The Role of microRNAs in the Tumorigenesis of Ovarian Cancer. Frontiers in Oncology. 3: 153. PMID 23785667 DOI: 10.3389/Fonc.2013.00153  0.49
2013 Di Leva G, Croce CM. MicroRNAs. Clinical Biochemistry. 46: 840-1. PMID 23726294 DOI: 10.1016/j.clinbiochem.2013.05.060  0.582
2013 Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. Plos Genetics. 9: e1003311. PMID 23505378 DOI: 10.1371/Journal.Pgen.1003311  0.601
2013 Di Leva G, Croce CM. miRNA profiling of cancer. Current Opinion in Genetics & Development. 23: 3-11. PMID 23465882 DOI: 10.1016/J.Gde.2013.01.004  0.493
2013 Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, et al. Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status Plos Genetics. 9. DOI: 10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46  0.48
2012 Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C, Bolon B, Condorelli G, Croce CM. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proceedings of the National Academy of Sciences of the United States of America. 109: 16570-5. PMID 23012423 DOI: 10.1073/Pnas.1207917109  0.636
2012 Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Molecular Oncology. 6: 458-72. PMID 22578566 DOI: 10.1016/J.Molonc.2012.03.003  0.595
2012 Di Leva G, Briskin D, Croce CM. MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Upsala Journal of Medical Sciences. 117: 202-16. PMID 22348396 DOI: 10.3109/03009734.2012.660551  0.504
2012 Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine. 18: 74-82. PMID 22157681 DOI: 10.1038/Nm.2577  0.606
2010 Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 18: 367-81. PMID 20951946 DOI: 10.1016/J.Ccr.2010.09.005  0.698
2010 Nuovo GJ, Wu X, Volinia S, Yan F, di Leva G, Chin N, Nicol AF, Jiang J, Otterson G, Schmittgen TD, Croce C. Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 19: 135-43. PMID 20736742 DOI: 10.1097/Pdm.0B013E3181C4Daaa  0.458
2010 Di Leva G, Croce CM. Roles of small RNAs in tumor formation Trends in Molecular Medicine. 16: 257-267. PMID 20493775 DOI: 10.1016/J.Molmed.2010.04.001  0.488
2010 Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, ... ... Di Leva G, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Research. 20: 589-99. PMID 20439436 DOI: 10.1101/Gr.098046.109  0.585
2010 Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. Journal of the National Cancer Institute. 102: 706-21. PMID 20388878 DOI: 10.1093/Jnci/Djq102  0.409
2009 Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 16: 498-509. PMID 19962668 DOI: 10.1016/J.Ccr.2009.10.014  0.678
2009 Levati L, Alvino E, Pagani E, Arcelli D, Caporaso P, Bondanza S, Di Leva G, Ferracin M, Volinia S, Bonmassar E, Croce CM, D'Atri S. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. International Journal of Oncology. 35: 393-400. PMID 19578755  0.489
2009 Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Ménard S, Croce CM, Tagliabue E. microRNA-205 regulates HER3 in human breast cancer. Cancer Research. 69: 2195-200. PMID 19276373 DOI: 10.1158/0008-5472.Can-08-2920  0.517
2007 Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM. MicroRNA signatures in human ovarian cancer. Cancer Research. 67: 8699-707. PMID 17875710 DOI: 10.1158/0008-5472.CAN-07-1936  0.632
2006 Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Research. 66: 10287-91. PMID 17079447 DOI: 10.1158/0008-5472.Can-06-2289  0.386
2006 Di Leva G, Calin GA, Croce CM. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Research. Part C, Embryo Today : Reviews. 78: 180-9. PMID 16847883 DOI: 10.1002/Bdrc.20073  0.459
2005 Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine. 353: 1793-801. PMID 16251535 DOI: 10.1056/Nejmoa050995  0.388
Show low-probability matches.